Hepatobiliary and Pancreatic Tumor Biobank
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
About this trial
This study aims to establish a hepatobiliary and pancreatic tumor biobank at the Second Affiliated Hospital of Zhejiang University School of Medicine. The biobank will systematically collect and store human biological samples, such as blood, tissue, bile, and other body fluids, together with relevant clinical and follow-up information from patients with hepatobiliary and pancreatic tumors, benign hepatobiliary and pancreatic diseases, and selected healthy volunteers.
The collection of samples will be performed without changing routine medical care and will not involve any experimental treatment or additional invasive procedures for research purposes. Biological samples will be obtained during standard clinical diagnosis and treatment, or from remaining specimens after routine clinical use.
All samples and data will be coded and stored according to ethical and legal requirements to protect participants' privacy. The biobank is intended to serve as a long-term research resource to support future basic, translational, and clinical research on hepatobiliary and pancreatic diseases, with the goal of improving understanding of disease mechanisms and advancing medical research in this field.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults aged 18 years or older.
Patients diagnosed with hepatobiliary or pancreatic malignant tumors, including but not limited to hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, and pancreatic cancer; or patients with benign hepatobiliary or pancreatic diseases; or selected healthy volunteers.
Receiving medical care or health evaluation at the Second Affiliated Hospital of Zhejiang University School of Medicine.
Able and willing to provide written informed consent, unless waived or exempted by the institutional ethics committee for retrospective samples.
Disqualifiers
Age younger than 18 years.
Unable to provide informed consent and without a legally authorized representative.
Presence of conditions that, in the opinion of the investigators, make participation inappropriate or infeasible.
Refusal to allow the collection or use of biological specimens or clinical data for research.
Trial population
The study population includes adult patients receiving care at the Second Affiliated Hospital of Zhejiang University School of Medicine who are diagnosed with hepatobiliary or pancreatic malignant tumors, as well as patients with benign hepatobiliary or pancreatic diseases. Selected healthy adult volunteers may also be included as controls. Participants are enrolled without altering routine medical care, and biological specimens and related clinical data are collected for biobanking and future research purposes.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
No Interventions
Other interventionThis is an observational biobank study. No experimental intervention, treatment, or procedure is assigned as part of the study. Biological specimens are collected only during routine clinical care or from remaining clinical specimens.
Treatment groups
300 Participants
are divided into 1 treatment groupGroup A: Hepatobiliary and Pancreatic Biobank Participants1 intervention
Trial outcomes
Primary outcomes
1
Successful Establishment of a Hepatobiliary and Pancreatic Tumor Biobank
Time frame
up to 5 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: